Last €0.08 EUR
Change Today -0.003 / -3.85%
Volume 0.0
LSM On Other Exchanges
Symbol
Exchange
Berlin
As of 2:08 AM 07/25/14 All times are local (Market data is delayed by at least 15 minutes).

lbt innovations ltd (LSM) Snapshot

Open
€0.08
Previous Close
€0.08
Day High
€0.08
Day Low
€0.08
52 Week High
05/16/14 - €0.13
52 Week Low
08/6/13 - €0.04
Market Cap
7.7M
Average Volume 10 Days
0.0
EPS TTM
--
Shares Outstanding
102.7M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for LBT INNOVATIONS LTD (LSM)

Related News

No related news articles were found.

lbt innovations ltd (LSM) Related Businessweek News

No Related Businessweek News Found

lbt innovations ltd (LSM) Details

LBT Innovations Limited researches and develops clinical and diagnostic technologies for the healthcare and laboratory supply markets in the United States, Switzerland, and Australia. It offers MicroStreak technology that enables an automated system for streaking biological samples onto agar plates; and automated plate assessment system, a platform technology for the automation of culture plate screening and interpretation. LBT Innovations Limited was founded in 2004 and is based in Adelaide, Australia.

Founded in 2004

lbt innovations ltd (LSM) Top Compensated Officers

Co-Founder, Chief Executive Officer, Managing...
Total Annual Compensation: A$308.0K
Vice President of Global Business Development
Total Annual Compensation: A$125.0K
Compensation as of Fiscal Year 2013.

lbt innovations ltd (LSM) Key Developments

LBT Innovations Introduces Diagnostic Platform

LBT Innovations Limited presented the first results from studies utilizing its breakthrough diagnostic technology to the international scientific community at Europe's larger gathering of the microbiology industry, the 24th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID). The presentation by LBT Scientific Director John Glasson provided some of the microbiologists and diagnostic companies with their first look at LBT's Automated Plate Assessment System (APAS), that is the subject of a joint venture with Swiss instrumentation company, Hettich AG Switzerland. The presentation, Initial evaluation of an image analysis device for the screening of cultures from clinical specimens, provided the first published clinical review of LBT's Intelligent Imaging Platform - a revolutionary platform for automating the analysis of biomedical imagery, based upon a sophisticated series of algorithms and medical reporting systems. Mr. Glasson's presentation reported the results of a trial late last year, in which cultures from a number of clinical sample types were screened by APAS and the results compared with those of a team of experienced microbiologists. The results showed that the automated system agreed with the microbiologists' findings, without missing a single potential pathogen. The ECCMID event also provided an opportunity for LBT's Vice President of Global Business Development, Peter Bradley, to deliver presentations on the practical benefits of APAS to a number of key opinion leaders attending the conference.

LBT Innovations Limited Reports Consolidated Earnings Results for the Six Months Ended December 31, 2013

LBT Innovations Limited reported consolidated earnings results for the six months ended December 31, 2013. For the period, revenue was AUD 2.370 million against AUD 451 million a year ago. Loss before income tax was AUD 1.672 million against AUD 1.479 million a year ago. Net loss for the period was AUD 866 million or 0.87 cents per diluted share against AUD 916 million or 0.92 cents per diluted share a year ago. Net cash provided by operating activities was AUD 1.204 million against net cash used in operating activities of AUD 0.502 million a year ago. Payment for Plant and Equipment was AUD 0.037 million against AUD 0.005 million a year ago.

LBT Innovations Limited, Annual General Meeting, Nov 26, 2013

LBT Innovations Limited, Annual General Meeting, Nov 26, 2013., at 15:30 Cen. Australia Standard Time. Location: Edwards Marshall, Chartered Accountants Level 3. Agenda: To receive and consider financial report and reports of the Directors and Auditor of the financial year ended June 30, 2013; to consider company performance and prospects; to adopt remuneration report for the year ended June 30, 2013; and to consider re-election of Robert Finder as a Director.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
LSM:GR €0.08 EUR -0.003

LSM Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for LSM.
View Industry Companies
 

Industry Analysis

LSM

Industry Average

Valuation LSM Industry Range
Price/Earnings 23.6x
Price/Sales 2.2x
Price/Book 1.1x
Price/Cash Flow 11.0x
TEV/Sales 1.9x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact LBT INNOVATIONS LTD, please visit www.lbtinnovations.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.